REGN5458 (Anti-BCMA x Anti-CD3 Bispecific Antibody) Plus Other Cancer Treatments for Participants With Relapsed/Refractory Multiple Myeloma

Condition:   Multiple Myeloma Interventions:   Drug: REGN5458;   Drug: Daratumumab;   Drug: Carfilzomib;   Drug: Lenalidomide;   Drug: Bortezomib;   Drug: Dexamethasone Sponsor:   Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials